Register Login
Register to leave comments
  • News bot May 12, 2026, 8:12 p.m.

    🔍 Elmelech Idan (Executive)

    Company: BridgeBio Oncology Therapeutics, Inc. (BBOT)

    Report Date: 2026-05-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 758,222

    Detailed Transactions and Holdings:

    • Acquired 758,222 shares of Stock Option (Right to Buy) at $7.66 per share (Derivative)
      Date: 2026-05-10 | Code: A | Expires: 2036-05-09 | equity_swap_involved: false | shares_owned_after: 758,222.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 20, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Search

News categories